loadpatents
Patent applications and USPTO patent grants for Biopheresis Technologies, Inc..The latest application filed is for "method and system to remove soluble tnfr1, tnfr2 and il2 in patients".
Patent | Date |
---|---|
Method And System To Remove Soluble Tnfr1, Tnfr2 And Il2 In Patients App 20130251672 - LENTZ; M. Rigdon | 2013-09-26 |
Method And Compositions For Treatment Of Cancers App 20130071350 - Lentz; M. Rigdon | 2013-03-21 |
Method and system to remove cytokine inhibitor in patients Grant 8,197,430 - Lentz June 12, 2 | 2012-06-12 |
Method and system to remove cytokine inhibitors in patients Grant 8,133,490 - Lentz March 13, 2 | 2012-03-13 |
Method and compositions for treatment of cancers Grant 7,854,717 - Lentz December 21, 2 | 2010-12-21 |
Method And System To Remove Soluble Tnfr1, Tnfr2, And Il2 In Patients App 20080145333 - Lentz; M. Rigdon | 2008-06-19 |
Method and system to remove soluble TNFR1, TNFR2, and IL2 in patients App 20050265996 - Lentz, M. Rigdon | 2005-12-01 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.